Industry Supported Sessions

THURSDAY, OCTOBER 27, 2022


12:30-13:30   Hall Alpha 5+6

ESGO Colloquium

Supported by Eisai & MSD

The Colloquium is organised by ESGO and supported by the industry, however the industry has no influence on the content of the programme or speaker selection.

Eisai
MSD Logo_300x300 px

ADVANCES IN ENDOMETRIAL CANCER

Chair: Nicole Concin (Austria/Germany)

Speakers:

The importance of the molecular classification as predictive factor in endometrial carcinoma: Carien Creutzberg (Netherlands)

The role of IO in in first-line endometrial cancer: Toon Van Gorp (Belgium)

The role of TKI’s in second-line recurrent endometrial cancer (lenvatinib, selinexor): Jose Alejandro Pérez-Fidalgo (Spain)

 

12:30-13:30   Hall Alpha 3+4

Industry symposium 1

Supported by Novocure

 

Novocure_main@5x-100

NEW PERSPECTIVES IN PLATINUM-RESISTANT OVARIAN CANCER:

TT FIELDS AND UPCOMING THERAPIES

 

Chairs: Jalid Sehouli (Germany) and Ignace Vergote (Belgium)

Speakers: Michael Sabel (USA), Susana Banerjee (UK), Isabelle Ray-Coquard (France), and David Cibula (Czech Republic)

FRIDAY, OCTOBER 28, 2022


07:30-08:30  Hall Alpha 3+4

Industry symposium 2

Supported by Mersana

Mersana logo - CMYK - vector - JPEG (002) (002)

ANTIBODY DRUG CONJUGATES IN TREATING PLATINUM-SENSITIVE OVARIAN CANCER: OPTIONS BEYOND PARPI

 

Chair: Mansoor Raza Mirza (Denmark)

Speakers: Susana Banerjee (UK), Philipp Harter (Germany), Antonio Gonzalez Martin (Spain)

 

 

12:30-13:30   Hall Aplha 5+6

Industry symposium 3

Supported by AstraZeneca

AstraZeneca_RGB_H_COL

LONG-TERM SURVIVAL FOR PATIENTS WITH NEWLY-DIAGNOSED ADVANCED OVARIAN CANCER:

WHAT IS THE GOAL, AND HOW CAN IT BE REACHED?

 

Chair: Ana Oaknin (Spain)

Speakers: Kathleen Moore (USA), Jonathan Ledermann (UK)

                               

12:30-13:30   Hall Alpha 3+4

Industry symposium 4

Supported by MSD

MSD Logo_300x300 px

EMERGING IO LANDSCAPE IN GYNECOLOGICAL CANCERS: ROLE OF BIOMARKER TESTING AND MDT APPROACHES

 

Chair: Domenica Lorusso (Italy)

Speaker: Hans Ulrich Schildhaus (Germany)

                               

14:40-15:40   Hall Alpha 3+4

Industry symposium 5

Supported by GSK

GSK_Logo-500x500

MANAGING PATIENTS WITH ENDOMETRIAL CANCER

Chair: Jalid Sehouli (Germany)

Speakers: Mansoor Mirza (Denmark), Lucy Gilbert (Canada), Christian Marth (Austria)

 

SATURDAY, OCTOBER 29, 2022


 

11:00-12:00   Hall Alpha 8

Industry symposium 6

Supported by GSK  

GSK_Logo-500x500

NEW HORIZONS IN ADVANCED OVARIAN CANCER: CONVERSATIONS AND CONTROVERSIES ON MANAGEMENT STRATEGIES

 

Chair: Philipp Harter (Germany)

Speakers: Antonio González Martín (Spain), Toon Van Gorp (Netherlands), Anne-Claire Hardy-Bessard (France)

 

11:00-12:00   Hall Alpha 5+6

Industry symposium 7

Supported by Seagen

Seagen Logo_RGB

PARADIGM SHIFT IN RECURRENT/METASTATIC CERVICAL CANCER? WHAT TO EXPECT AND WHAT TO LOOK FOR?

Chair: Ignace Vergote (Belgium)

Speakers: Isabelle Ray-Coquard (France), David Cibula (Czech Republic), Domenica Lorusso (Italy), Ana Oaknin (Spain), Linn Wölber (Germany)

 

11:00-12:00   Hall Alpha 3+4

Industry symposium 8

Supported by Intuitive  

INTUITIVE logo blue on white 553x305px

INTEGRATION OF ROBOTIC-ASSISTED SURGERY IN YOUR GYO PROGRAM

 

Chair: Ane Gerda Eriksson (Norway)

Speakers: Jan Persson (Sweden), Philippe Van Trappen (Netherlands), Ingolf Juhasz-Böss (Germany)

 

You may also like

ESGO_2015_24102015_0296_WEB

Reasons to Attend

on demand

ESGO 2022

Scientific Programme & iPlanner

 

Explore it Now!

prague

Photo Gallery

Great moments from ESGO 2021!

 

View it Now!

register

Registration